drugset / Trial / NCT02062073
Dermal Safety Study to Evaluate the Sensitizing Potential of Abametapir Lotion
Phase 1
Completed
238 enrolled
Dr. Reddy's Laboratories Limited
Accelovance · collabTKL Research, Inc. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Purpose of this study will be to determine the potential of abametapir lotion to induce sensitization by repeated topical application to the healthy skin of humans under controlled conditions.
Timeline
- Start
- 2014-01
- Primary completion
- 2014-03
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Abametapir | Small molecule | 0.2 ml | Topical |